INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,938 | +39.3% | 94,956 | +59.9% | 0.00% | – |
| Q2 2023 | $26,520 | -99.6% | 59,396 | -92.6% | 0.00% | -100.0% |
| Q4 2020 | $7,062,000 | +115.6% | 797,994 | +182.5% | 0.03% | +138.5% |
| Q3 2020 | $3,276,000 | -68.8% | 282,448 | -27.4% | 0.01% | -75.5% |
| Q2 2020 | $10,486,000 | +1484.0% | 389,093 | +130.2% | 0.05% | +1666.7% |
| Q2 2018 | $662,000 | -16.8% | 169,000 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $796,000 | – | 169,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |